In the next 5 years, will the bioeconomy be the outlet?

"Meeting the people's growing needs for a better life is the fundamental purpose of developing the bio-economy
.
" Wang Xiang, deputy director of the High Technology Department of the National Development and Reform Commission, said in the "14th Five-Year Plan" Bio-economy Development Plan recently held by the National Development and Reform Commission.
” said at a press conference
.

The "Planning" clearly states that efforts should be made to expand and strengthen the bio-economy.
By 2025, the bio-economy will become a strong driving force for high-quality development.
A new leap forward has been achieved in development, biosafety assurance capability has reached a new level, and the policy environment in the biological field has opened up a new situation
.
It is reported that the "Plan" is China's first five-year bioeconomy plan
.

Remarkable achievements in the innovation and development of bio-economy

"Since the 18th National Congress of the Communist Party of China, China has made remarkable achievements in the innovation and development of bio-economy
.
" Wang Xiang said that artemisinin has achieved "zero breakthrough" in the Nobel Prize in the field of natural science in China, and the number of innovative drugs under development ranks second in the world.
Comparative advantages have been formed in the fields of genetic testing, super rice, artificial starch, and vaccines, and technological breakthroughs are constantly emerging
.
At the same time, industrial innovation continued to be active
.
In recent years, the field of biology has become a hot spot for investment, with biological companies accounting for 1/3 of the companies listed on the Science and Technology Innovation Board.
During the "13th Five-Year Plan" period, the R&D investment of pharmaceutical companies above designated size increased by about 8% annually
.
The volume of biological manufacturing has been further expanded, and modern biological fermentation products account for more than 70% of the global share
.

"Beijing-Tianjin-Hebei, the Yangtze River Delta, the Guangdong-Hong Kong-Macao Greater Bay Area, and the Chengdu-Chongqing Economic Circle have become national bioeconomy innovation highlands
.
About 80% of listed companies, 90% of national first-class new drugs, and 85% of specially approved products for innovative medical devices come from these regions.
The regional agglomeration effect is obvious
.
" Wang Xiang further introduced
.

But at the same time, it should be noted that "China's bio-economy innovation and development still faces many challenges
.
" Wang Xiang said, for example, the original innovation capability is still relatively weak, basic life science theories, underlying key common technologies, high-end instruments and reagents, biological information The accumulation of resources and other factors is not enough, the technological innovation system with enterprises as the main body, market-oriented, and deep integration of production, education and research is still not perfect, and there are still relatively few enterprises with international competitiveness
.

To this end, the "Plan" adheres to the problem orientation and deploys to improve the innovation capability of the bio-economy from four aspects
.
The first is to accelerate the improvement of biotechnology innovation capabilities
.
Aim at key areas to implement major national science and technology projects and key R&D plans, deploy leading national major science and technology infrastructure in advance, and build a national strategic science and technology force in the biological field
.
The second is to cultivate and strengthen innovative entities with strong competitiveness
.
Strengthen the main body of enterprise innovation, give play to the leading and supporting role of leading enterprises, cultivate individual champions in subdivided fields, and support leading enterprises to take the lead in forming innovation consortia
.
The third is to optimize the regional layout of innovation and development
.
Guide innovation resources to gather in key areas, implement special promotion actions for key industries, pilot reform measures, and create bio-economy innovation poles and bio-industry innovation highlands
.
Fourth, deepen cooperation in bio-economy innovation
.
Encourage domestic scientific research institutions to take the initiative to initiate and participate in major international scientific programs, encourage enterprises to speed up their integration into the international market, and promote key products to "go global"
.

Wang Xiang said that innovation is the primary driving force for development and the strategic support for building a modern economic system
.
For the development and expansion of the bio-economy, "innovation" is the "bull nose", grasping innovation is grasping development, and seeking innovation is seeking the future
.

The biopharmaceutical industry performed well

"The biopharmaceutical industry is an important part of the bioeconomy, a strategic emerging industry related to the national economy and people's livelihood and national security, and an important foundation for the construction of a healthy China
.
In recent years, the biopharmaceutical industry has developed vigorously.
In the face of the sudden new crown pneumonia epidemic, China's biological The complete industrial chain and strong supply capacity of the pharmaceutical industry have not only withstood the test of the epidemic, but also made important contributions to the prevention and control of the epidemic and the realization of stable economic development due to the advantages of a complete industrial system, strong mobilization and organizational capabilities and resilience
.
” said Zhou Jian, deputy director of the Consumer Goods Industry Department of the Ministry of Industry and Information Technology
.

It is understood that in 2021, the added value of China's pharmaceutical industry will increase by 23.
1% year-on-year, and the growth rate will increase by 15.
3 percentage points compared with the same period in 2020, which is 13.
5 percentage points higher than the overall growth rate of all industries
.
The proportion of the added value of the pharmaceutical industry in the total industrial added value continued to rise, accounting for 4.
1%, and its role in stabilizing industrial economic growth was further enhanced
.
The operating income was 3,370.
75 billion yuan, a cumulative year-on-year increase of 18.
7%, an increase of 11.
4 percentage points over the same period in 2020, and the growth rate reached a new high in the past five years
.
The total profit achieved was 708.
75 billion yuan, a year-on-year increase of 67.
3%
.

"Under the background of the country's encouragement of innovation, China's pharmaceutical innovation has entered the fast lane.
The investment in pharmaceutical research and development and the number of new drugs under development have increased significantly.
The number of varieties that have completed clinical research applications for listing is increasing, and the number of approved innovative products has shown a rapid increase year by year.

In 2021, the number of innovative drugs and innovative medical devices approved for marketing in China will reach a new high, the highest level in the past five years
.
" Zhou Jian said
.

The pharmaceutical industry is related to people's life and health, is an important focus of bio-economic development, and has played an important role in the prevention and control of the new crown pneumonia epidemic
.
According to Zhou Jian, in 2021, sub-sectors such as biological drug manufacturing, genetic engineering drugs and vaccine manufacturing will achieve operating income of 591.
8 billion yuan, a year-on-year increase of 113.
8%; the proportion of realized profits in the total profits of the pharmaceutical industry will reach 41.
7%, which will effectively promote the industry.
overall development
.

Meet the diverse and multi-level health needs of the masses

"The "Planning" proposes to develop biopharmaceuticals oriented to people's life and health to meet the people's new expectations for more secure life and health
.
The Ministry of Industry and Information Technology has also specially issued the "14th Five-Year Plan for the Development of the Pharmaceutical Industry" to provide A series of measures have been put forward to promote the development of the pharmaceutical industry
.
" Zhou Jian said that in the next step, the Ministry of Industry and Information Technology will work with relevant departments to implement the new development concept based on the new development stage, comprehensively improve the modernization level of the pharmaceutical industry, and better meet the needs of the people.
Diversified and multi-level health needs of the masses
.

"Fully grasp the new trend of accelerated iteration of global biotechnology, strengthen the layout of frontier and original innovation fields, move from 'following' innovation to 'leading' innovation, encourage the deep integration of industry, academia, research and medicine, and promote the research and development of a number of new drugs and new medical devices and industrialization, and strive to achieve 'parallel running' and even 'leading' in some fields
.
" Zhou Jian said that it is necessary to improve the innovation service system and support pharmaceutical companies to strengthen cooperation with national laboratories, scientific research institutions, high-level research universities and other institutions.
Integrate and gather innovation resources, form a cross-domain, large-scale collaboration, and high-intensity innovation base, jointly build a national strategic scientific and technological force in the field of biomedicine, and promote the orderly connection and joint development of the transformation of achievements
.

"Biotechnology is one of the most important innovative technology clusters in the 21st century.
It has remarkable characteristics such as breakthrough and leadership, especially in promoting the high-quality development of society and people's livelihood
.
" Xu Hang, deputy director of the Science and Technology Promotion and Development Bureau of the Chinese Academy of Sciences He said that as a national strategic scientific and technological force, the Chinese Academy of Sciences has always adhered to the frontier of science and technology in the world, the major needs of the country, the main battlefield of the national economy, and the life and health of the people
.
During the "14th Five-Year Plan" period, we will continue to deploy and optimize cutting-edge biotechnology research with major application prospects, make breakthroughs in solving a series of key core technologies and "stuck neck" problems, promote the high-quality development of bio-economy-related industries, and help China's biological High-level scientific and technological self-reliance and self-reliance and the construction of a biological power
.